ProstateHealthGuide.org launched for Prostate Health Month
September 02, 2015 14:25 ET
|
Men's Health Network
WASHINGTON, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Men's Health Network has launched a new website in celebration of Prostate Health Month this September. The website- www.prostatehealthguide.com -will...
Photo Release -- Innovative Solution Delivers Freedom for Men With Incontinence
January 30, 2014 09:10 ET
|
BioDerm, Inc.
LARGO, Fla., Jan. 30, 2014 (GLOBE NEWSWIRE) -- Four (4) million American men have urinary incontinence. They spend $13 billion a year on diapers, catheters and care. Until now, incontinence was...
Study Shows Botanical Formula Fights Prostate Cancer
April 04, 2012 10:58 ET
|
Better Health Publishing
SANTA ROSA, Calif., April 4, 2012 (GLOBE NEWSWIRE) -- A non-toxic, botanical formula controls aggressive human prostate tumors in mice, according to a peer-reviewed study in the The International...
New Study From Columbia University Gives Hope to Men With Prostate Cancer
June 14, 2010 15:26 ET
|
Dr. Isaac Eliaz
SANTA ROSA, CA--(Marketwire - June 14, 2010) - Prostate cancer is the second leading cause of cancer death in men, and 1 in 6 will get prostate cancer during his lifetime. With nearly 200,000...
Patient Outcomes Impacted by Surgical Volume
February 11, 2010 08:00 ET
|
Memorial Hermann
HOUSTON, Feb. 11, 2010 (GLOBE NEWSWIRE) -- A recent study published in The Journal of Urology suggests that prostate cancer patients treated by more experienced urologic surgeons achieve improved...
CombiMatrix Announces Positive Preliminary Data on Non-Invasive, Cancer Screening Test
February 26, 2009 06:00 ET
|
CombiMatrix Corporation
MUKILTEO, Wash., Feb. 26, 2009 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) today announced positive preliminary data on its investigational Comprehensive Cancer Array (CCA) test showing...
Yale Researchers Present Results of Phase II Phenoxodiol Clinical Trial in Prostate Cancer Patients at ASCO 2009 Genitourinary Cancers Symposium
February 24, 2009 08:00 ET
|
Marshall Edwards, Inc.
ORLANDO, FL--(Marketwire - February 24, 2009) - Marshall Edwards, Inc. (NASDAQ: MSHL) --
Preliminary results from a Phase II clinical trial of oral phenoxodiol in
patients with prostate cancer to be...
Marshall Edwards, Inc. Files IND Application for Triphendiol
December 01, 2008 08:10 ET
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - December 1, 2008) - Marshall Edwards, Inc. (NASDAQ: MSHL) today
announced that it has filed an application with the United States Food and
Drug Administration for an...
Donedei Wines to Host Charitable Event for Robotic-Assisted Prostate Cancer Surgery
July 17, 2008 12:00 ET
|
Donedei
OLYMPIA, WA--(Marketwire - July 17, 2008) - One in six men will be diagnosed with prostate
cancer in their lifetime, according to the National Cancer Institute. When
Fred Goldberg, co-founder of...
Yale Cancer Center Sponsors Study of Phenoxodiol for Prostate Cancer
October 22, 2007 19:25 ET
|
Marshall Edwards, Inc.
NEW HAVEN, CT--(Marketwire - October 22, 2007) - Yale researchers have begun recruiting 60 men
for a clinical trial investigating an experimental new drug, oral
phenoxodiol, as a potential first line...